Medical researchers are steps from legalizing ecstasy. Here’s how they did it.
“Regulators, governments, health economists, health systems, insurers, health-care professionals, and—most importantly—patients,” said George Goldsmith, the former CEO of McKinsey & Company’s TomorrowLab, and an advocate for the kind of therapeutic innovation psychedelic researchers are hoping to achieve. “That’s the next community that actually needs to be engaged here.” For Doblin, it represents a life’s effort,…
Recent Comments